AzTrials
AzTrials

OlderNCT07554118

Postural Control in Adults

A study testing restricted vision (no-V) and full vision (full-V) in people with Older and Adults, run by University of Oklahoma at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators propose a 2-week intervention involving adults over 65 years old. Participants will undergo dynamic balance training on an movable platform (stabilometer) with either restricted or full vision. Read more about this study

Who is it for?
Ages 65 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Older, Adults, Older Adults, Balance
What is being tested?
restricted vision (no-V) and full vision (full-V)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
30 Jan 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • age 65 and above
  • able to walk continuously for at least 10 min without assistive device
  • have normal or corrected-to-normal vision.

Who cannot join

  • neurological conditions such as stroke, Parkinson's disease, multiple sclerosis, brain tumor that significantly affect balance task and walking
  • known peripheral neuropathy that influence sensation
  • known vestibular dysfunction
  • known cognitive impairments
  • self-reported pain or musculoskeletal conditions that will significantly affect balance task and walking.
  • Drug use in the past 3 month.
  • At-risk drinker -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yo Shih, PhD contact

405-271-2131

Yo-shih@ou.edu

United States1 site, 1 recruiting
  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73117

    Yo Shih, PhD, 405-353-2602, yo-shih@ou.edu

    Recruiting

Other trials in United States

About this study

Official title: Enhancing Postural Control in Older Adults by Increasing Somatosensory Contribution

The investigators propose a 2-week intervention involving adults over 65 years old. Participants will undergo dynamic balance training on an movable platform (stabilometer) with either restricted or full vision. The primary objective is to facilitate sensory re-weighting, hypothesizing that restricted vision training will increase somatosensory input utilization for postural control. Pre- and post-training assessments will measure postural control during gait initiation under a dual-task condition. The investigators hypothesize that the restricted vision group will demonstrate:

  1. Improved postural control, indicated by increased center of pressure displacement during gait initiation.
  2. Improved ability to utilize somatosensory input during a balance task.
Read the detailed description

Participants. All participants will sign written informed consent before their participation. The inclusion criteria are: 1) age 65 and above, 2) able to walk continuously for at least 10 min without assistive device, 2) have normal or corrected-to-normal vision. The exclusion criteria are: 1) neurological conditions such as stroke, Parkinson's disease, multiple sclerosis, brain tumor that significantly affect balance task and walking, 2) known peripheral neuropathy that influence sensation, 3) known vestibular dysfunction, 4) known cognitive impairments, 4) self-reported pain or musculoskeletal conditions that will significantly affect balance task and walking. Prior to enrolling in the study, the general purpose, procedures, and potential risks of the study will be explained to the potential participant and consent secured. Participants will be allocated to the no-V or the full-V group using a computerized random generator. The statistician will develop a randomization schedule and will issue it to the researchers before patient recruitment. Participants will be assigned to intervention groups using a block randomization scenario to keep the two groups even.

Baseline assessment. Demographic information will be collected in the 1st visit. Participants will complete questionnaires to record demographics and quantify physical activity level, quality of life, and psychological characteristics. Clinical outcomes regarding balance ability and proprioception assessment will also be performed. The information, surveys, and clinical outcomes collected at baseline assessments are listed in Table 1. Instrumentation. A stabilometer (Lafayette Instrument, Lafayette, IN, USA, Fig. 1) will be used for the training of the dynamic balance task. Outcome measures will be recorded in a motion analysis lab using force plates (AMTI, Watertown, MA, USA) for the center of pressure trajectory displacements. Intervention protocol. The experiment will take place over a 3-week period including screening and pre-intervention testing (1st visit), six dynamic balance training sessions (2nd to 7th visits), and post-intervention testing (8th visit). The six training sessions will be accomplished in 2 weeks. The dynamic balance training. The 2 weeks dynamic balance training involves standing and maintaining balance on a stabilometer, which consists of a platform (1.3m long by 1.4m wide) connected to a single axis that allows bidirectional sway (Lafayette Instrument Co.; Fig. 2). The maximum angular deviation of the platform is 18°. A safety harness may be provided to prevent falls but does not provide support during the performance of the task. Participants are required to maintain balance with feet in a medio-lateral orientation while standing on the balance board. A potentiometer monitors the sway angle of the platform. An integrated timer measures time in balance, which is defined as when the platform angle is within ± 5° of horizontal. The participants will be encouraged to maintain the platform in horizontal for as long as possible within a 30 s trial. Participants assigned to no-V group will perform the task with blind-fold.

Aim 1 Method Rationale. A critical component of gait, i.e. gait initiation, which is a destabilization process from static standing to continuous walking, provides an appropriate window to examine the integration of sensory and motor function. Compared to young adults, older adults demonstrate longer preparation time and reduced posterior displacement of center of pressure (CoP) trajectory as the individual prepares to accelerate the center of mass forward during gait initiation.21,22 Postural control during gait initiation are predictive of fall risk and have been used to examine the effects of selective interventions on sensorimotor integration during walking.38,39 This has direct clinical implications, as gait initiation is ecologically relevant to walking. Instrumentation. A force plate (AMTI, Watertown, MA, USA) will be used to capture the trajectory of the center of pressure during gait initiation. Procedures. Gait initiation will be performed at the pre-intervention and post-intervention testing. The participants will stand on a force plate with both legs, feet are should-width apart. The participant will be instructed to perform mathematic calculations (i.e. subtract seven consecutively from a three-digit number) and speak out the answers while standing on a force plate. The participants will be instructed to initiate walking while performing the cognitive tasks. They will be walking along a 7 m walk way as quickly as they safely can after a visual LED cue indicates the side of leg for gait initiation. The participant will be asked to continue walking for 3 m for one walking trial. Data processing and analysis. The posterior displacement of the center of pressure (CoP) will be measured by the displacement of the CoP trajectory from the initial CoP position to the maximum posterior position in the anterior-posterior direction (Fig 3). Expected outcomes. After 2 weeks of the dynamic balance training, The investigators expect to see a greater increase in the posterior displacement of the CoP trajectory during gait initiation in the no-V group (Fig 4).

Aim 2 Method Rationale. The Modified Clinical Test for Sensory Interaction on Balance (CTSIB-M) is used clinically for balance analysis and to determine the dependence of the individual on all sensory systems (i.e. vision, vestibular and somatosensory) during balance tasks. The CTSIB-M has been shown to have excellent reliability in older adults and predictive to future fall incidence 40,41. Procedures. To perform the CTSIB-M, the participants stands with their hands at their side with the goal to stand as steady as possible for 30 s, under four different conditions (i.e. stand on firm surface with eyes-open, stand on firm surface with eyes-closed, stand on compliant surface with eyes-open, stand on compliant surface with eyes-closed). The investigators will collect three trials in each condition. Each trial will be timed with a stop watch, and the timer stops when the participant moves their arms, shows more than minimal body sway, and lose their balance or take a step. The test will be carried out on a force plate which will record the center of pressure trajectory for a secondary quantitative analysis regarding the amplitude of body sway. Data processing and analysis. The time in balance of the four conditions will be compared pre- and post- intervention using repeated measures ANOVA. Expected outcomes. The investigators expect that the no-V group will show improved time in balance in the "stand on firm surface with eyes-closed" condition which focuses on to evaluate the contribution of somatosensory inputs during the standing balance task.

Being tested
restricted vision (no-V), full vision (full-V)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • restricted vision (no-V)Behavioural

    no-V group will perform the dynamic balance task with blind-fold.

    The 2 weeks dynamic balance training involves standing and maintaining balance on a stabilometer, which consists of a platform (1.3m long by 1.4m wide) connected to a single axis that allows bidirectional sway (Lafayette Instrument Co.; Fig. 2). The maximum angular deviation of the platform is 18°. A safety harness may be provided to prevent falls but does not provide support during the performance of the task. Participants are required to maintain balance with feet in a medio-lateral orientation while standing on the balance board. A potentiometer monitors the sway angle of the platform. An integrated timer measures time in balance, which is defined as when the platform angle is within ± 5° of horizontal. The participants will be encouraged to maintain the platform in horizontal for as long as possible within a 30 s trial. Participants assigned to no-V group will perform the task with blind-fold.

  • full vision (full-V)Behavioural

    The participants will be performing the dynamic balance training with their full vision.

Study groups in NCT07554118
Study groupRoleWhat they receive
restricted vision (no-V)ExperimentalThe participant will be blind-folded in the following dynamic balance training. The 2 weeks dynamic balance training involves standing and maintaining balance on a stabilometer, which consists of a platform (1.3m long by 1.4m wide) connected to a single axis that allows bidirectional sway (Lafayette Instrument Co.; Fig. 2). The maximum angular deviation of the platform is 18°. A safety harness may be provided to prevent falls but does not provide support during the performance of the task. Participants are required to maintain balance with feet in a medio-lateral orientation while standing on the balance board. A potentiometer monitors the sway angle of the platform. An integrated timer measures time in balance, which is defined as when the platform angle is within ± 5° of horizontal. The participants will be encouraged to maintain the platform in horizontal for as long as possible within a 30 s trial. Participants assigned to no-V group will perform the task with blind-fold.
Receives: Behavioral: restricted vision (no-V)
full vision (full-V)Active comparatorThe participants in this arm will be doing the dynamic balance training with eyes open. The 2 weeks dynamic balance training involves standing and maintaining balance on a stabilometer, which consists of a platform (1.3m long by 1.4m wide) connected to a single axis that allows bidirectional sway (Lafayette Instrument Co.; Fig. 2). The maximum angular deviation of the platform is 18°. A safety harness may be provided to prevent falls but does not provide support during the performance of the task. Participants are required to maintain balance with feet in a medio-lateral orientation while standing on the balance board. A potentiometer monitors the sway angle of the platform. An integrated timer measures time in balance, which is defined as when the platform angle is within ± 5° of horizontal. The participants will be encouraged to maintain the platform in horizontal for as long as possible within a 30 s trial. Participants assigned to no-V group will perform the task with blind-fold
Receives: Behavioral: full vision (full-V)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dynamic postural control

    The center of pressure displacement during gait initiation under a single and a dual-task condition will be measured.

    Measured: From enrollement to one week within the last training days (within 3 weeks from enrollment)

  2. Somatosensory reliance during static standing

    The center of pressure displacement during static standing with eye-closed.

    Measured: From enrollment to within one week after the last day of training (within three weeks from enrollment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2026
  2. Study start30 Jan 2026
  3. Primary completionOct 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07554118
Sponsor's protocol ID
17943P
Status last verified
Apr 2026
First submitted
13 Apr 2026
Last updated
28 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Only deidentified data points will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing restricted vision (no-V) and full vision (full-V) in people with Older and Adults, run by University of Oklahoma at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yo Shih, PhD (405-271-2131, Yo-shih@ou.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dynamic postural control (time frame: From enrollement to one week within the last training days (within 3 weeks from enrollment)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in